Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

The global Natural Killer (NK) Cell Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Natural Killer (NK) Cell Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Natural Killer (NK) Cell Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Natural Killer (NK) Cell Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Natural Killer (NK) Cell Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application
Cancer
Cardiovascular Diseases
Others